checkAd
    Supernus Pharmaceuticals Aktie
    30,83
     
    USD
    +1,85 %
    +0,56 USD
    Letzter Kurs 02:00:00 Nasdaq
    30,82
     
    USD
    100 STK
    Geldkurs 03.05.24
    30,84
     
    USD
    100 STK
    Briefkurs 03.05.24
    ISIN: US8684591089 · WKN: A1JX3U · SYM: SUPN · USA

    Neueste Nachrichten

    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of Investors
    02.05.24 · Business Wire (engl.) · Supernus Pharmaceuticals
    Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
    01.05.24 · globenewswire · Supernus Pharmaceuticals
    The Law Offices of Frank R. Cruz Announces Investigation of Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of Investors
    30.04.24 · Business Wire (engl.) · Supernus Pharmaceuticals
    Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
    24.04.24 · globenewswire · Supernus Pharmaceuticals
    Fokus Aktien mit extremen Handelsvolumen am Montag, den 08.04.2024
    08.04.24 · wO Chartvergleich · Aaon
    Supernus Provides Regulatory Update for SPN-830
    08.04.24 · globenewswire · Supernus Pharmaceuticals
    Supernus to Participate in Two Upcoming Investor Conferences
    06.03.24 · globenewswire · Supernus Pharmaceuticals
    Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
    28.02.24 · globenewswire · Supernus Pharmaceuticals
    Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
    27.02.24 · globenewswire · Supernus Pharmaceuticals
    Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024
    13.02.24 · globenewswire · Supernus Pharmaceuticals
    Supernus Wins Infringement and Validity Case on Trokendi XR against Torrent
    05.02.24 · globenewswire · Supernus Pharmaceuticals
    Supernus to Participate in the Jefferies London Healthcare Conference
    07.11.23 · globenewswire · Supernus Pharmaceuticals